← Open Payments lookup

PAOLA DEGREGORIO: Open Payments

NPI 1720147085 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,753 in 50 payments from 16 companies in 2025. Trend: 2023 $565 · 2024 $758 · 2025 $1,753

Food & beverage: $1,753
CompanyPaymentsAmount
Eisai Inc.7$280
AstraZeneca Pharmaceuticals LP2$261
Incyte Corporation2$253
Bayer Healthcare Pharmaceuticals Inc.9$229
Deciphera Pharmaceuticals Inc.2$135
Merck Sharp & Dohme LLC6$126
Novartis Pharmaceuticals Corporation5$116
ABBVIE INC.5$89
Ipsen Biopharmaceuticals, Inc3$68
Daiichi Sankyo Inc.3$67

Products named: Lenvima, Stivarga, IMFINZI, QINLOCK, Pemazyre, KEYTRUDA, Zynyz, LUTATHERA.

Industry payments across NY — which companies pay providers there.